NCT02963753|Completed
Hyperemesis Gravidarum and 75 Gram Oral Glucose Tolerance Test
Effect of Hyperemesis Gravidarum on 75 Gram Oral Glucose Tolerance Test Screening and Gestational Diabetes Mellitus
Loading search results
Effect of Hyperemesis Gravidarum on 75 Gram Oral Glucose Tolerance Test Screening and Gestational Diabetes Mellitus
Sponsor study identifier
observational
560
0 countries
N/A
Study Start
January 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2016
Actual (reported)Study Completion
November 2016
Actual (reported)Hyperemesis gravidarum (HEG) is not only nausea and vomiting of pregnancy, but it is also a clinical syndrome including endocrine and metabolic complications. Recently, some investigators have been begun performing researches related to the development of gestational diabetes mellitus (GDM) in pregnant women with HEG because they think about those metabolic and endocrine complications of HEG.In the literature there are few studies assessing how HEG has effects on GDM or 75 gram oral glucose tolerance test (OGTT). So the investigators aim to evaluate the effects of HEG on 75 gram OGTT.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2016
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2016
Date type not reportedThis date has not been verified as actual or estimated.
November 2016
Actual (reported)November 2016
Actual (reported)November 10, 2016
Actual (reported)November 15, 2016
Actual (reported)To determine serum glucose levels in both groups during 75 gram oral glucose tolerance test screening
3 months
The study group consisted of women hospitalized for hyperemesis during first trimester of their pregnancy
whereas the control group included all other women who delivered in the same period.
This study was carried out with two groups. The study group consisted of women hospitalized for HEG during first trimester of their pregnancy, whereas the control group included all other women who delivered in the same period. When the pregnant women had those symptoms such as the presence of intractable vomiting during pregnancy associated with dehydration, electrolyte,and/or metabolic disturbances, as well as a weight loss 5% or more, they were diagnosed as HEG.
YUSUF MADENDAG
Kayseri Education and Research Hospital
560 participants (actual enrollment reported by the registry).
First Submitted
November 10, 2016
First Posted
November 15, 2016
Study Start
January 2016
Date type not reportedThis date has not been verified as actual or estimated.
Late Metabolic Effects of Metformin Therapy in Gestational Diabetes
Contact the study team to confirm eligibility.
Primary Completion
November 2016
Actual (reported)Study Completion
November 2016
Actual (reported)Last Updated
April 13, 2017
Record last verified: 2017-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: